DBV Technologies S.A. (DBVT) vs REGENXBIO (RGNX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
REGENXBIO (RGNX) has outperformed DBV Technologies S.A. (DBVT) over the past year, losing 27.7% versus a loss of 31.4%. Over five years, DBVT leads with a -7.8% price change compared with -78.9% for RGNX. DBV Technologies S.A. is the larger company by market cap ($614.0 million vs $501.4 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DBVT | RGNX |
|---|---|---|
| Share price | $9.77 | $7.60 |
| Market cap | $614.03M | $501.37M |
| 1-day change | -2.10% | +1.95% |
| YTD return | -49.03% | -47.26% |
| 1-year return | -31.39% | -27.74% |
| 5-year return | -7.83% | -78.87% |
| EPS (TTM) | $-3.46 | $-3.85 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $26.19 | $16.19 |
| 52-week low | $9.64 | $5.46 |
| Distance from 52-week high | -62.69% | -53.09% |
| Average volume | 328.30K | 1.53M |
| Shares outstanding | 62.85M | 66.01M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
DBVT vs RGNX FAQ
Which is bigger, DBV Technologies S.A. or REGENXBIO?
DBV Technologies S.A. (DBVT) is larger, with a market capitalization of $614.03M compared with $501.37M for REGENXBIO (RGNX).
Which stock has performed better over the past year, DBVT or RGNX?
RGNX returned -27.74% over the past 12 months, compared with -31.39% for DBVT (price return, excluding dividends). Past performance does not predict future results.
Are DBV Technologies S.A. and REGENXBIO in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.